Literature DB >> 1756490

Simultaneous analysis of chromosomal aneusomy and 5-bromodeoxyuridine incorporation in MCF-7 breast tumor cell line.

M Balazs1, B H Mayall, F M Waldman.   

Abstract

We describe a new method to determine simultaneously both proliferative status and chromosome copy number within individual interphase cells. The MCF-7 human breast cancer cell line was used as a model system to characterize proliferative activity in karyotypically defined cell subpopulations. Cells were labeled with bromodeoxyuridine (BrdU) in vitro and incorporation was monitored with IU4 mouse anti-BrdU. Biotinylated, digoxigenin-labeled, or acetylamino-fluorene-conjugated repetitive sequence DNA probes were hybridized to target interphase nuclei. Three-color fluorescence labeling allowed simultaneous detection of two chromosome pairs and designation of cells undergoing DNA synthesis. This technique may also be used for simultaneous characterization of proliferative and karyotypic heterogeneity in primary human tumors.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1756490     DOI: 10.1016/0165-4608(91)90194-y

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  5 in total

Review 1.  Cytochemical detection systems for in situ hybridization, and the combination with immunocytochemistry, 'who is still afraid of red, green and blue?'.

Authors:  E J Speel; F C Ramaekers; A H Hopman
Journal:  Histochem J       Date:  1995-11

Review 2.  Bromodeoxyuridine: a diagnostic tool in biology and medicine, Part II: Oncology, chemotherapy and carcinogenesis.

Authors:  F Dolbeare
Journal:  Histochem J       Date:  1995-12

3.  Sporadic amplification of the insulin receptor gene in human breast cancer.

Authors:  V Papa; G Milazzo; I D Goldfine; F M Waldman; R Vigneri
Journal:  J Endocrinol Invest       Date:  1997-10       Impact factor: 4.256

4.  Hematopoietic progenitor cells residing in muscle engraft into bone marrow following transplantation.

Authors:  Kathrin Terres Bauermeister; Stephanie Stölting; Piotr M Kaczmarek; Roger Nadrowitz; Thomas Wagner; Stefan O Peters
Journal:  Int J Hematol       Date:  2004-06       Impact factor: 2.490

5.  Misbehaviour of XIST RNA in breast cancer cells.

Authors:  Silvia M Sirchia; Silvia Tabano; Laura Monti; Maria P Recalcati; Manuela Gariboldi; Francesca R Grati; Giovanni Porta; Palma Finelli; Paolo Radice; Monica Miozzo
Journal:  PLoS One       Date:  2009-05-15       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.